ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 973,03
-0,43%
Dow Jones
44 303,40
-0,99%
DAX
21 787,00
-0,58%
Brent Oil
74,565
0,00%
Bitcoin
96 032,12
-0,45%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Aadi Bioscience Inc (AADI) Cours

Aadi Bioscience Inc

Aadi Bioscience Inc (AADI)

NASDAQ
2,77
-0,06
(-2,12%)
Fermé 09 Février 10:00PM
Retardé de 15 minutes
2,77
0,00
(0,00%)
Après les heures de négociation: 11:59PM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
2,77
Prix Achat
2,74
Prix Vente
3,14
Volume échangé
67 105
2,72 Fourchette du Jour 2,90
1,21 Plage de 52 semaines 3,812
Cap du marché
68,273M
Clôture Veille
2,83
Ouverture
2,85
Dernière Transaction
960
@
2.77
Dernière heure de transaction
Volume financier
US$ 186 755
VWAP
2,783
Volume moyen (3 m)
368 885
Actions en circulation
24 647 392
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,04
Bénéfice par action (BPA)
-2,67
Chiffre d'affairess
24,35M
Bénéfice net
-65,77M

À propos de Aadi Bioscience Inc

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other ... Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.aadibio.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Aadi Bioscience Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker AADI. Le dernier cours de clôture d'Aadi Bioscience était de US$2,83. Au cours de la dernière année, les actions de Aadi Bioscience ont été négociées dans une fourchette de prix de US$ 1,21 à US$ 3,812.

Aadi Bioscience compte actuellement 24 647 392 actions en circulation. La capitalisation boursière d'Aadi Bioscience est de US$69,75 million. Aadi Bioscience a un ratio cours/bénéfice (ratio PE) de -1.04.

AADI Dernières nouvelles

Plus de nouvelles

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

05 Février 2025
Edgar (US Regulatory)

Aadi Bioscience Filed Definitive Proxy Statement and Schedules Special Meeting of Stockholders for February 28, 2025

Aadi Bioscience Filed Definitive Proxy Statement and Schedules Special Meeting of Stockholders for February 28, 2025 PR Newswire MORRISTOWN, N.J., Feb. 5, 2025 Proxy Statement Includes Proposals...

05 Février 2025
PR Newswire (US)

Form DEFM14A - Definitive proxy statement relating to merger or acquisition

31 Janvier 2025
Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

30 Janvier 2025
Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

24 Janvier 2025
Edgar (US Regulatory)

Form PREM14A - Preliminary proxy statements relating to merger or acquisition

21 Janvier 2025
Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

30 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

23 Décembre 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

23 Décembre 2024
Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

23 Décembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.09-3.146853146852.862.97822.6616923142.79945811CS
4-0.86-23.69146005513.633.652.66161959193.10007885CS
120.6329.43925233642.143.8122.023688853.14001556CS
261.3392.36111111111.443.8121.212845222.53588715CS
520.9955.61797752811.783.8121.212707582.25948031CS
156-15.44-84.788577704618.2121.151.211965885.38446299CS
260-27.23-90.76666666673032.991.211907367.28593957CS

AADI - Frequently Asked Questions (FAQ)

What is the current Aadi Bioscience share price?
The current share price of Aadi Bioscience is US$ 2,77
How many Aadi Bioscience shares are in issue?
Aadi Bioscience has 24 647 392 shares in issue
What is the market cap of Aadi Bioscience?
The market capitalisation of Aadi Bioscience is USD 69,75M
What is the 1 year trading range for Aadi Bioscience share price?
Aadi Bioscience has traded in the range of US$ 1,21 to US$ 3,812 during the past year
What is the PE ratio of Aadi Bioscience?
The price to earnings ratio of Aadi Bioscience is -1,04
What is the cash to sales ratio of Aadi Bioscience?
The cash to sales ratio of Aadi Bioscience is 2,8
What is the reporting currency for Aadi Bioscience?
Aadi Bioscience reports financial results in USD
What is the latest annual turnover for Aadi Bioscience?
The latest annual turnover of Aadi Bioscience is USD 24,35M
What is the latest annual profit for Aadi Bioscience?
The latest annual profit of Aadi Bioscience is USD -65,77M
What is the registered address of Aadi Bioscience?
The registered address for Aadi Bioscience is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Aadi Bioscience website address?
The website address for Aadi Bioscience is www.aadibio.com
Which industry sector does Aadi Bioscience operate in?
Aadi Bioscience operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MGOLMGO Global Inc
US$ 0,4191
(126,54%)
816,59M
CDTConduit Pharmaceuticals Inc
US$ 2,831
(82,65%)
144,17M
GSIWGarden Stage Ltd
US$ 0,79
(78,73%)
219,64M
TOIIWOncology Institute Inc
US$ 0,033
(58,88%)
7,27k
CYTHCyclo Therapeutics Inc
US$ 1,19
(54,55%)
84,73M
FTELFitell Corporation
US$ 2,70
(-57,01%)
2,3M
SGBXSafe and Green Holdings Corporation
US$ 0,6401
(-44,82%)
5,65M
NKLANikola Corporation
US$ 0,4432
(-41,10%)
52,44M
PLRXPliant Therapeutics Inc
US$ 7,785
(-34,85%)
6,44M
LIPOLipella Pharmaceuticals Inc
US$ 3,08
(-33,76%)
2,2M
MGOLMGO Global Inc
US$ 0,4191
(126,54%)
780,46M
RIMEAlgorhythm Holdings Inc
US$ 0,0169
(-20,66%)
262,79M
GSIWGarden Stage Ltd
US$ 0,79
(78,73%)
215,16M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0537
(14,74%)
210,78M
NVDANVIDIA Corporation
US$ 129,84
(0,90%)
209,04M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
AADI
Aadi Bioscience
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces